• 4163 Citations
  • 10 h-Index
1993 …2019
If you made any changes in Pure these will be visible here soon.

Research Output 1993 2019

  • 4163 Citations
  • 10 h-Index
  • 21 Article
  • 1 Comment/debate
  • 1 Review article
2019
4 Citations (Scopus)

TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial)

Ioka, T., Ueno, M., Ueno, H., Park, J. O., Chang, H. M., Sasahira, N., Kanai, M., Chung, I. J., Ikeda, M., Nakamori, S., Mizuno, N., Omuro, Y., Yamaguchi, T., Hara, H., Sugimori, K., Furuse, J., Maguchi, H., Furukawa, M., Fukuzawa, K., Kim, J. S. & 5 others, Yukisawa, S., Takeuchi, M., Okusaka, T., Boku, N. & Hyodo, I., 2019 Jan 1, In : European Journal of Cancer. 106, p. 78-88 11 p.

Research output: Contribution to journalArticle

Open Access
gemcitabine
Leucovorin
Pancreatic Neoplasms
Survival
Korea
2018
Venous Thromboembolism
Pancreatic Neoplasms
Retrospective Studies
Drug Therapy
gemcitabine
2017
1 Citation (Scopus)

Is noncurative gastrectomy always a beneficial strategy for stage IV gastric cancer?

Lee, C. M., Choi, I. K., Kim, J. H., Park, D. W., Kim, J. S. & Park, S-H., 2017 Jan 1, In : Annals of Surgical Treatment and Research. 92, 1, p. 23-29 7 p.

Research output: Contribution to journalArticle

Gastrectomy
Stomach Neoplasms
Drug Therapy
Survival
Cause of Death
2016
1 Citation (Scopus)
gemcitabine
Proton Pump Inhibitors
Gastritis
Pancreatic Neoplasms
Radiation
2014
15 Citations (Scopus)

Using modified RECIST and alpha-fetoprotein levels to assess treatment benefit in hepatocellular carcinoma

Raoul, J. L., Park, J. W., Kang, Y. K., Finn, R. S., Kim, J. S., Yeo, W., Polite, B. N., Chao, Y., Walters, I., Baudelet, C. & Lencioni, R., 2014 Apr 16, In : Liver Cancer. 3, 3-4, p. 439-450 12 p.

Research output: Contribution to journalReview article

alpha-Fetoproteins
Hepatocellular Carcinoma
Therapeutics
Fibroblast Growth Factors
Response Evaluation Criteria in Solid Tumors
2013
25 Citations (Scopus)

Awareness of incurable cancer status and health-related quality of life among advanced cancer patients: A prospective cohort study

Lee, M. K., Baek, S. K., Kim, S. Y., Heo, D. S., Yun, Y. H., Park, S. R. & Kim, J. S., 2013 Feb 1, In : Palliative Medicine. 27, 2, p. 144-154 11 p.

Research output: Contribution to journalArticle

Cohort Studies
Quality of Life
Prospective Studies
Neoplasms
Drug Therapy
2012
252 Citations (Scopus)

Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: A multicentre, open-label, randomised, phase 3 study

Lee, J., Park, S. H., Chang, H. M., Kim, J. S., Choi, H. J., Lee, M. A., Chang, J. S., Jeung, H. C., Kang, J. H., Lee, H. W., Shin, D. B., Kang, H. J., Sun, J. M., Park, J. O., Park, Y. S., Kang, W. K. & Lim, H. Y., 2012 Feb 1, In : The Lancet Oncology. 13, 2, p. 181-188 8 p.

Research output: Contribution to journalArticle

oxaliplatin
gemcitabine
Biliary Tract Neoplasms
Drug Therapy
Cholangiocarcinoma
2011
129 Citations (Scopus)

Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma

Park, J. W., Finn, R. S., Kim, J. S., Karwal, M., Li, R. K., Ismail, F., Thomas, M., Harris, R., Baudelet, C., Walters, I. & Raoul, J. L., 2011 Apr 1, In : Clinical Cancer Research. 17, 7, p. 1973-1983 11 p.

Research output: Contribution to journalArticle

Disease-Free Survival
Hepatocellular Carcinoma
Survival Rate
Therapeutics
Safety
2009
3188 Citations (Scopus)

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Cheng, A. L., Kang, Y. K., Chen, Z., Tsao, C. J., Qin, S., Kim, J. S., Luo, R., Feng, J., Ye, S., Yang, T. S., Xu, J., Sun, Y., Liang, H., Liu, J., Wang, J., Tak, W. Y., Pan, H., Burock, K., Zou, J., Voliotis, D. & 1 others, Guan, Z., 2009 Jan 1, In : The Lancet Oncology. 10, 1, p. 25-34 10 p.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Placebos
Safety
sorafenib
Diarrhea
232 Citations (Scopus)

Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study

Faivre, S., Raymond, E., Boucher, E., Douillard, J., Lim, H. Y., Kim, J. S., Zappa, M., Lanzalone, S., Lin, X., DePrimo, S., Harmon, C., Ruiz-Garcia, A., Lechuga, M. J. & Cheng, A. L., 2009 Aug 1, In : The Lancet Oncology. 10, 8, p. 794-800 7 p.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Safety
Hand-Foot Syndrome
Asthenia
sunitinib
2008
35 Citations (Scopus)

Belotecan, new camptothecin analogue, is active in patients with small-cell lung cancer: Results of a multicenter early phase II study

Lee, D. H., Kim, S. W., Suh, C., Lee, J. S., Lee, J. H., Lee, S. J., Ryoo, B. Y., Park, K., Kim, J. S., Heo, D. S. & Kim, N. K., 2008 Jan 1, In : Annals of Oncology. 19, 1, p. 123-127 5 p.

Research output: Contribution to journalArticle

Camptothecin
Small Cell Lung Carcinoma
Drug Therapy
belotecan
Korea
98 Citations (Scopus)

Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: A national survey of the Korean Cancer Study Group

Kim, T. M., Lee, S. Y., Jeon, Y. K., Ryoo, B. Y., Cho, G. J., Hong, Y. S., Kim, H. J., Kim, S. Y., Kim, C. S., Kim, S., Kim, J. S., Sohn, S. K., Song, H. H., Lee, J. L., Kang, Y. K., Yim, C. Y., Lee, W. S., Yuh, Y. J., Kim, C. W. & Heo, D. S., 2008 Aug 11, In : Annals of Oncology. 19, 8, p. 1477-1484 8 p.

Research output: Contribution to journalArticle

Natural Killer T-Cells
T-Cell Lymphoma
Nose
Natural Killer Cells
Survival
31 Citations (Scopus)

Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas

Lee, J., Kim, T. Y., Lee, M. A., Ahn, M. J., Kim, H. K., Lim, H. Y., Lee, N. S., Park, B. J. & Kim, J. S., 2008 Jan 1, In : Cancer Chemotherapy and Pharmacology. 61, 1, p. 47-52 6 p.

Research output: Contribution to journalArticle

gemcitabine
Biliary Tract
Cisplatin
Carcinoma
Toxicity
2006
6 Citations (Scopus)

Change in Patients' Satisfaction with Pain Control After Using the Korean Cancer Pain Assessment Tool in Korea

Choi, Y. S., Kim, S. H., Kim, J. S., Lee, J., Kang, J. H., Kim, S. Y., Kim, S. Y., Kim, C. S., Song, H. S., Lim, H. Y., Yim, C. Y., Chung, I. J., Cho, G. J., Lee, M. A., Park, J. & Yeom, C. H., 2006 Jun 1, In : Journal of Pain and Symptom Management. 31, 6, p. 553-562 10 p.

Research output: Contribution to journalArticle

Pain Measurement
Korea
Patient Satisfaction
Pain
Cancer Pain

Erratum (Retracted article): Reliability and validity of the Korean Cancer Pain Assessment Tool (KCPAT) (Journal of Korean Medical Science (2005) 20, (877-882))

Kim, J. A., Choi, Y. S., Lee, J., Park, J., Myung, A. L., Chang, H. Y., Se, K. J., Duck, M. Y. & Kim, J. S., 2006 Dec 1, In : Journal of Korean Medical Science. 21, 6, 1 p.

Research output: Contribution to journalComment/debate

Pain Measurement
Reproducibility of Results
Cancer Pain
2005
7 Citations (Scopus)

Reliability and validity of the korean cancer pain assessment tool (KCPAT) (Retraction in: Journal of Korean Medical Science (2006) 21:6 (1139))

Kim, J. A., Choi, Y. S., Lee, J., Park, J., Myung, A. L., Chang, H. Y., Se, K. J., Duck, M. Y. & Kim, J. S., 2005 Oct 1, In : Journal of Korean Medical Science. 20, 5, p. 877-882 6 p.

Research output: Contribution to journalArticle

Pain Measurement
Reproducibility of Results
Pain
Neoplasms
Health Services Needs and Demand
2 Citations (Scopus)
Neoplasm RNA
Keratin-20
Ki-67 Antigen
Tumor Biomarkers
Keratins
2004
128 Citations (Scopus)

The attitudes of cancer patients and their families toward the disclosure of terminal illness

Yun, Y. H., Lee, C. G., Kim, S. Y., Lee, S. W., Heo, D. S., Kim, J. S., Lee, K. S., Hong, Y. S., Lee, J. S. & You, C. H., 2004 Dec 1, In : Journal of Clinical Oncology. 22, 2, p. 307-314 8 p.

Research output: Contribution to journalArticle

Disclosure
Neoplasms
Odds Ratio
Korea
2002
7 Citations (Scopus)

Simultaneous duodenal and colon masses as late presentation of metastatic renal cell carcinoma.

Lee, J. G., Kim, J. S., Kim, H. J., Kim, S. T., Yeon, J. E., Byun, K. S., Kim, J. S., Bak, Y-T. & Lee, C. H., 2002 Jun 1, In : Korean Journal of Internal Medicine. 17, 2, p. 143-146 4 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Colon
Ascending Colon
Nephrectomy
Duodenum
1996

Diffuse infiltrative lung disease: Comparison of diagnostic accuracies of high-performance CT and radiography

Kim, K. A., Kang, E-Y., Oh, Y. W., Kim, J. S., Park, J. S., Lee, K. S., Kang, K. H. & Chung, K. B., 1996 Nov 22, In : Tuberculosis and Respiratory Diseases. 43, 3, p. 388-402 15 p.

Research output: Contribution to journalArticle

Radiography
Lung Diseases
Thorax
Miliary Tuberculosis
Idiopathic Pulmonary Fibrosis
1995
2 Citations (Scopus)

A study of mucocutaneous manifestations due to cancer chemotherapy

Oh, Y. S., Seo, S-H., Kye, Y. C., Kim, J. S. & Oh, C. H., 1995 Jan 1, In : Korean Journal of Dermatology. 33, 3, p. 474-481 8 p.

Research output: Contribution to journalArticle

Alopecia
Drug Therapy
Neoplasms
Stomatitis
Hyperpigmentation
Small Cell Lung Carcinoma
Vincristine
Etoposide
Combination Drug Therapy
Cyclophosphamide
1993

A case of rhabdomyosarcoma arising at the pleura

Lee, J. G., Choi, K. M., Shin, S. W., In, K. H., Kang, K. H., Kim, J. S., Yoo, S. H., Won, N. H. & Lee, Y. S., 1993 Jan 1, In : Tuberculosis and Respiratory Diseases. 40, 3, p. 308-313 6 p.

Research output: Contribution to journalArticle

Rhabdomyosarcoma
Pleura
Drug Therapy